KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.98

Characterization of the effect of naltrexone/bupropion on body composition.

Vanessa Tardio, Peter Yin, Fernando Camacho, Maxime Barakat, Michael A Tsoukas

Diabetes Obes Metab 27(5) 2397-2404

PMID39927409
PMCIDPMC11965020
DOI10.1111/dom.16235
发表日期2025-02-10
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

AIMS: Oral treatment extended-release naltrexone/bupropion (NB) leads to significant weight loss, but its effect on body composition remains unclear. We investigated changes in body composition with dual-energy x-ray absorptiometry after treatment with NB or placebo in a subgroup of participants from a randomized control phase 3 study (COR-I). MATERIALS AND METHODS: Observed changes from baseline to week 52 were estimated for total, lean, and fat mass. Changes in body composition were evaluated using linear regression and adjusted for baseline covariates. RESULTS: The analysis included 82 participants (placebo, n = 26; NB, n = 56) with comparable baseline characteristics (age, BMI, sex). The NB group experienced a significant -7.8% change of total mass (-12.9% change in fat mass and -4.1% in lean mass), compared with a -2.8% change of total mass (-4.8% change in fat mass and -1.4% in lean mass) in the placebo group. The adjusted changes in lean-to-fat mass ratio of 0.069 in the NB group and -0.056 in the placebo group were significantly different (p < 0.05). CONCLUSIONS: NB-induced weight loss is associated with significant reductions in total percent fat mass, increase in total percent lean mass, and change in lean-to-fat mass ratio, in comparison to placebo. Larger studies are needed to further elucidate the clinical significance of these changes and impact of a potentially healthier metabolism.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。